tiprankstipranks
Trending News
More News >
Aoba-BBT. Inc. (JP:2464)
:2464
Japanese Market

Aoba-BBT. Inc. (2464) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2464

Aoba-BBT. Inc.

(2464)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
¥382.00
▲(14.37% Upside)
Aoba-BBT. Inc. demonstrates solid financial performance with consistent revenue growth and strong balance sheet indicators, contributing significantly to its overall score. The technical analysis suggests a neutral to slightly bearish trend, which slightly dampens the overall outlook. The valuation is reasonable, with an attractive dividend yield, supporting the stock's appeal. The absence of earnings call data and corporate events does not impact the score due to their exclusion.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for Aoba-BBT's products and services, suggesting a robust market position and potential for future expansion.
Balance Sheet Strength
A strong balance sheet with low leverage enhances financial stability and provides flexibility for strategic investments and growth opportunities.
Cash Generation
Improving cash generation capabilities support sustainable operations and provide resources for reinvestment, debt reduction, or shareholder returns.
Negative Factors
Profit Margin Stability
Modest profit margins may limit the company's ability to absorb cost increases or invest aggressively in growth, impacting long-term competitiveness.
Cash Flow Volatility
Cash flow volatility can pose challenges in financial planning and may affect the company's ability to consistently fund operations and growth initiatives.
Sector Challenges
Operating in the education sector may present challenges due to regulatory changes and evolving market demands, potentially impacting long-term growth.

Aoba-BBT. Inc. (2464) vs. iShares MSCI Japan ETF (EWJ)

Aoba-BBT. Inc. Business Overview & Revenue Model

Company DescriptionAoba-BBT, Inc. (2464) is a leading company specializing in the development and distribution of innovative biotechnology solutions. The company operates primarily in the healthcare sector, focusing on creating advanced products that enhance patient care and improve clinical outcomes. Its core offerings include diagnostic tools, therapeutic agents, and research services aimed at addressing critical health challenges in various medical fields.
How the Company Makes MoneyAoba-BBT, Inc. generates revenue through multiple streams, primarily by selling its biotechnology products and services to hospitals, clinics, and research institutions. The company earns income from the direct sale of its diagnostic tools and therapeutic agents, which are often priced based on their advanced technology and effectiveness. Additionally, Aoba-BBT enters into strategic partnerships with pharmaceutical companies and research organizations, enabling collaborative projects that can lead to shared revenue from new product developments. Grant funding and contracts with government entities for research initiatives also contribute to the company's financial performance, allowing it to expand its product offerings and enhance its market presence.

Aoba-BBT. Inc. Financial Statement Overview

Summary
Aoba-BBT. Inc. exhibits solid financial health with consistent revenue growth, stable profit margins, and strong balance sheet indicators. The company maintains low leverage, strong equity levels, and improving cash flow generation. While profit margins are relatively modest, the stability and growth in revenue and cash flows suggest a well-managed company in the education sector.
Income Statement
75
Positive
Aoba-BBT. Inc. has demonstrated consistent revenue growth with a revenue increase from 2024 to 2025 of 3.02%. The gross profit margin for 2025 was 36.91%, and the net profit margin was stable at 3.15%. The EBIT margin improved slightly to 5.72% in 2025. While EBITDA margin improved to 10.56%, the stability of net income suggests a moderate level of profitability. The steady growth coupled with stable margins reflects solid performance in the education sector.
Balance Sheet
80
Positive
The company's balance sheet is strong, with a low debt-to-equity ratio of 0.025, indicating low leverage and financial risk. The return on equity is stable, reflecting effective utilization of shareholder funds. The equity ratio remains robust at 61.63%, showcasing a solid financial position with a good proportion of equity financing. Overall, Aoba-BBT's balance sheet highlights stability and prudent financial management.
Cash Flow
70
Positive
Aoba-BBT has shown improvement in free cash flow from 2024 to 2025, with a significant positive turnaround. The operating cash flow to net income ratio of 4.52 indicates strong cash generation relative to net income. The free cash flow to net income ratio is also healthy, reflecting the company's ability to generate cash beyond its capital expenditures. Overall, the cash flow statements depict improving cash generation capabilities, though volatility in prior periods suggests ongoing monitoring is necessary.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue7.77B7.70B7.47B7.26B6.76B5.89B
Gross Profit2.96B2.84B2.96B2.99B3.05B2.72B
EBITDA826.14M813.46M764.21M1.51B846.48M466.41M
Net Income260.56M242.70M242.66M723.95M221.69M100.32M
Balance Sheet
Total Assets7.94B7.40B7.49B8.62B8.85B8.40B
Cash, Cash Equivalents and Short-Term Investments3.41B2.77B2.29B3.22B1.64B1.89B
Total Debt106.25M112.50M137.50M205.51M1.90B1.64B
Total Liabilities3.51B2.84B2.72B3.61B4.43B3.90B
Stockholders Equity4.43B4.56B4.75B4.98B4.41B4.49B
Cash Flow
Free Cash Flow0.001.03B-585.84M956.75M-64.70M522.42M
Operating Cash Flow0.001.10B-428.19M1.12B582.71M869.53M
Investing Cash Flow0.00-174.25M46.62M2.31B-1.05B-341.12M
Financing Cash Flow0.00-449.19M-547.28M-1.85B213.18M22.25M

Aoba-BBT. Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price334.00
Price Trends
50DMA
343.16
Negative
100DMA
346.93
Negative
200DMA
340.26
Negative
Market Momentum
MACD
-2.09
Negative
RSI
42.59
Neutral
STOCH
61.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2464, the sentiment is Negative. The current price of 334 is below the 20-day moving average (MA) of 337.25, below the 50-day MA of 343.16, and below the 200-day MA of 340.26, indicating a bearish trend. The MACD of -2.09 indicates Negative momentum. The RSI at 42.59 is Neutral, neither overbought nor oversold. The STOCH value of 61.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2464.

Aoba-BBT. Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥4.39B9.532.60%8.85%-1.34%
68
Neutral
¥4.76B17.843.25%3.46%13.31%
67
Neutral
¥3.18B11.1025.00%13.82%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
¥4.73B25.8313.50%-19.59%
55
Neutral
¥2.93B25.851.68%-4.16%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2464
Aoba-BBT. Inc.
336.00
29.32
9.56%
JP:2179
Seigakusha Co., Ltd.
788.00
9.28
1.19%
JP:5575
Globee Inc.
620.00
-273.00
-30.57%
JP:6096
RareJob,Inc.
313.00
-35.72
-10.24%
JP:7353
KIYO Learning Co Ltd
685.00
-10.00
-1.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 30, 2025